Hantz Financial Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.31M | Sell |
40,087
-1,825
| -4% | -$196K | 0.07% | 227 |
|
|
2025
Q1 | $4.23M | Buy |
41,912
+8,808
| +27% | +$889K | 0.07% | 223 |
|
|
2024
Q4 | $2.96M | Sell |
33,104
-263
| -0.8% | -$23.5K | 0.05% | 277 |
|
|
2024
Q3 | $2.8M | Buy |
33,367
+263
| +0.8% | +$22K | 0.05% | 292 |
|
|
2024
Q2 | $2.55M | Buy |
33,104
+65
| +0.2% | +$5.01K | 0.05% | 295 |
|
|
2024
Q1 | $2.26M | Buy |
33,039
+205
| +0.6% | +$14K | 0.04% | 326 |
|
|
2023
Q4 | $1.9M | Buy |
32,834
+844
| +3% | +$48.8K | 0.04% | 341 |
|
|
2023
Q3 | $1.69M | Buy |
31,990
+27,026
| +544% | +$1.43M | 0.04% | 334 |
|
|
2023
Q2 | $269K | Hold |
4,964
| – | – | 0.01% | 520 |
|
|
2023
Q1 | $248K | Hold |
4,964
| – | – | 0.01% | 526 |
|
|
2022
Q4 | $230K | Buy |
4,964
+4,211
| +559% | +$195K | 0.01% | 525 |
|
|
2022
Q3 | $29K | Hold |
753
| – | – | ﹤0.01% | 638 |
|
|
2022
Q2 | $28K | Sell |
753
-20
| -3% | -$744 | ﹤0.01% | 637 |
|
|
2022
Q1 | $34K | Sell |
773
-56,040
| -99% | -$2.46M | ﹤0.01% | 643 |
|
|
2021
Q4 | $2.41M | Buy |
56,813
+3,748
| +7% | +$159K | 0.07% | 251 |
|
|
2021
Q3 | $2.3M | Buy |
53,065
+7,808
| +17% | +$339K | 0.08% | 233 |
|
|
2021
Q2 | $1.94M | Buy |
45,257
+1,084
| +2% | +$46.3K | 0.07% | 245 |
|
|
2021
Q1 | $1.71M | Buy |
44,173
+408
| +0.9% | +$15.8K | 0.07% | 243 |
|
|
2020
Q4 | $1.57M | Buy |
+43,765
| New | +$1.57M | 0.07% | 235 |
|